Factor viii
Products billed under this code include Hemofil M, Koate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Hemofil M, Koate.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Hemofil M | Takeda Pharmaceuticals America, Inc. | 00944-3940-02 | 1 | $1.248 |
| Hemofil M | Takeda Pharmaceuticals America, Inc. | 00944-3942-02 | 1 | $1.248 |
| Hemofil M | Takeda Pharmaceuticals America, Inc. | 00944-3944-02 | 1 | $1.248 |
| Hemofil M | Takeda Pharmaceuticals America, Inc. | 00944-3946-02 | 1 | $1.248 |
| Koate | Kedrion Biopharma Inc | 76125-0257-25 | 1 | $1.248 |
| Koate | Kedrion Biopharma Inc | 76125-0663-50 | 1 | $1.248 |
| Koate | Kedrion Biopharma Inc | 76125-0679-12 | 1 | $1.248 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.248 | +$0.002 | 1 IU | Factor viii | v1, posted September 17, 2026 |
| 3Q26 | $1.246 | −$0.147 | 1 IU | Factor viii | v1, posted September 15, 2026 |
| 2Q26 | $1.393 | +$0.28 | 1 IU | Factor viii | v1, posted September 15, 2026 |
| 1Q26 | $1.113 | +$0.028 | 1 IU | Factor viii | v1, posted September 15, 2026 |
| 4Q25 | $1.085 | −$0.045 | 1 IU | Factor viii | v1, posted September 8, 2026 |
| 3Q25 | $1.13 | +$0.014 | 1 IU | Factor viii | v1, posted March 10, 2026 |
| 2Q25 | $1.116 | −$0.001 | 1 IU | Factor viii | v1, posted March 10, 2026 |
| 1Q25 | $1.117 | −$0.054 | 1 IU | Factor viii | v1, posted December 19, 2025 |
| 4Q24 | $1.171 | +$0.088 | 1 IU | Factor viii | v1, posted June 11, 2025 |
| 3Q24 | $1.083 | −$0.027 | 1 IU | Factor viii | v1, posted June 11, 2025 |
| 2Q24 | $1.11 | +$0.083 | 1 IU | Factor viii | v1, posted March 11, 2025 |
| 1Q24 | $1.027 | −$0.161 | 1 IU | Factor viii | v1, posted December 19, 2024 |
| 4Q23 | $1.188 | +$0.159 | 1 IU | Factor viii | v1, posted October 10, 2024 |
| 3Q23 | $1.029 | −$0.10 | 1 IU | Factor viii | v1, posted June 5, 2024 |
| 2Q23 | $1.129 | +$0.025 | 1 IU | Factor viii | v1, posted February 23, 2024 |
| 1Q23 | $1.104 | −$0.026 | 1 IU | Factor viii | v1, posted December 6, 2023 |
| 4Q22 | $1.13 | −$0.014 | 1 IU | Factor viii | v1, posted June 22, 2023 |
| 3Q22 | $1.144 | +$0.073 | 1 IU | Factor viii | v1, posted June 9, 2023 |
| 2Q22 | $1.071 | −$0.04 | 1 IU | Factor viii | v1, posted December 14, 2022 |
| 1Q22 | $1.111 | −$0.011 | 1 IU | Factor viii | v1, posted June 8, 2022 |
| 4Q21 | $1.122 | +$0.007 | 1 IU | Factor viii | v1, posted June 2, 2022 |
| 3Q21 | $1.115 | +$0.105 | 1 IU | Factor viii | v1, posted June 2, 2022 |
| 2Q21 | $1.01 | −$0.06 | 1 IU | Factor viii | v1, posted March 1, 2022 |
| 1Q21 | $1.07 | – | 1 IU | Factor viii | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.